Mid-Atlantic BioTherapeutics (Worldwide Rights of IMT504) is Buildings and Property in United States that focus on portfolio business. They cover business area such as portfolio, right, Doylestown, Pennsylvania, symptomatic rabie, orphan drug designation, significant benefit, tax credit, market exclusivity, waiver, certain FDA fee.
-
Portfolio
-
Doylestown, PA
United States
Private
portfoliorightDoylestownPennsylvaniasymptomatic rabieorphan drug designationsignificant benefittax creditmarket exclusivitywaivercertain FDA fee
* We use standard office opening hours in near Mid-Atlantic BioTherapeutics (Worldwide Rights of IMT504)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Mid-Atlantic BioTherapeutics (Worldwide Rights Of IMT504) is Buildings and Property business from United States that founded in - ( years old in ), Mid-Atlantic BioTherapeutics (Worldwide Rights of IMT504) business is focusing on Portfolio.
Mid-Atlantic BioTherapeutics (Worldwide Rights of IMT504) headquarter office and corporate office address is located in Doylestown, PA United States.
Mid-Atlantic BioTherapeutics (Worldwide Rights of IMT504) was founded in United States.
In , Mid-Atlantic BioTherapeutics (Worldwide Rights of IMT504) is currently focus on portfolio sector.
Above is snippet of Google Trends for "portfolio" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Mid-Atlantic BioTherapeutics (Worldwide Rights of IMT504), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
